The company was founded in 1949 and is headquartered in Dublin, Ireland. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The stock has an overall B rating, which indicates a Buy in our proprietary rating system. MDT’s strong fundamentals are reflected in its POWR Ratings. Wall Street analysts expect the stock to hit 131.47 in the near term, which indicates a potential 25.3 upside. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The stock closed yesterday’s trading session at 104.97. It operates through the following segments: Cardiac and Vascular Group Minimally Invasive Technologies Group Restorative Therapies Group and Diabetes Group. Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |